Navigation Links
Shared survival mechanism explains why 'good' nerve cells last and 'bad' cancer cells flourish
Date:12/15/2008

CHAPEL HILL Cancer cells and nervous system neurons may not look or act alike, but both use strikingly similar ways to survive, according to new research from the University of North Carolina at Chapel Hill School of Medicine.

The study published in the December issue of Nature Cell Biology is the first to describe how neurons (nerve cells) and cancer cells achieve the common goal of inhibiting the series of biochemical events called apoptosis that eventually causes cells to break down and die.

That's good in the case of neurons, but bad when it comes to cancer.

"In neurons, inhibiting cell death is physiologically important to ensuring their long term survival," said the study's lead author, neurobiologist Mohanish Deshmukh, Ph.D., associate professor of cell and developmental biology and member of the Lineberger Comprehensive Cancer Center. "In cancer cells, blocking cell death allows them to evade the host defense systems and proliferate uncontrollably."

Both neurons and cancer cells do have something in common: relying extensively on the metabolism of glucose, a simple sugar. But until now, the advantages of this common characteristic have remained unclear.

"One reason why these results are so interesting is that neurons and cancer cells are as different from each other as you can imagine. For example, cancer cells divide continuously, whereas neurons don't divide at all," Deshmukh said.

In their research, Deshmukh and UNC graduate student Allyson Vaughn (currently a postdoctoral scientist at MIT) found that to prevent death, neurons and cancer cells use a specific metabolic pathway, or series of chemical reactions. This pathway the pentose phosphate biochemical pathway inhibits the activation of a key protein involved in the process of cell death called cytochrome c. "What we show is that both neurons and cancer cells inhibit the cell death process mediated by cytochrome c," Deshmukh said.

Specifically, according to the study, cytochrome c's ability to induce death can be turned off if the cellular environment contains high levels of antioxidants. Healthy neurons and cancer cells have increased levels of the antioxidant glutathione (GSH), which is generated by glucose metabolism through the pentose phosphate pathway. Thus, both neurons and cancer cells are able to resist cell death in part via their reliance on glucose metabolism.

"For neurons and cancer cells, evolution has come up with ways to restrict the cell death pathway. Our results provide insight into the mechanism behind this adaptive advantage," Deshmukh said. "They also bring together the fields of cancer and neurobiology and suggest that the mechanisms used by neurons to evade cell death could be the same ones adapted by dividing cells during their progression toward cancer."

The UNC scientist said his lab's further systematic explorations for other similarities between these cell types may offer insights into turning the cell death process back on in cancer cells.


'/>"/>

Contact: Les Lang
llang@med.unc.edu
919-966-9366
University of North Carolina School of Medicine
Source:Eurekalert

Related biology news :

1. UI and ISU establish shared DNA sequencing instrumentation
2. Salmon smolt survival similar in Columbia and Fraser rivers
3. Research challenges conventional notions about salmon survival
4. Similar survival rates for Pacific salmon in Fraser, Columbia Rivers raises new questions
5. U of MN study shows link between gene variations and cancer survival
6. Second lumpectomy for breast cancer reduces survival rates
7. The IMF says journal editorial documents dramatic increase in survival since the 1980s
8. International team reveals first prognosticator of survival in aggressive cancer
9. The MDS Foundation supports the FDAs decision to expand vidaza label to include survival data
10. Monash researchers uncover cancer survival secrets
11. Scientists find elephant memories may hold key to survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):
(Date:4/26/2017)... ... 26, 2017 , ... WonderWorks, Myrtle Beach’s science focused amusement ... of deep space exploration and inspire space enthusiasts. The exhibit features interactive exhibits ... guest appearance by former Shuttle Astronaut Don Thomas. , The intergalactic weekend kicks ...
(Date:4/26/2017)... ... April 26, 2017 , ... As the call ... healthcare industry stakeholders, the discussion surrounding the topic will continue at WEDI 2017- ... in Los Angeles, Calif. Hosted by the Workgroup for Electronic Data Interchange (WEDI), ...
(Date:4/25/2017)... R.I. , April 25, 2017 ... Inc. ("EpiVax") has licensed its novel immune-modulating technology to ... autoimmune disease and allergy. Tregitopes, pronounced ... in human immunoglobulin by EpiVax CEO Annie ... Similar to intravenous immunoglobulin G, an autoimmune disease ...
(Date:4/24/2017)... , April 24, 2017  Dante Labs announced today the ... EUR 850 (ca. $900). While American individuals have been able ... time Europeans can access WGS below EUR 1,000. ... to leveraging genetic information to make informed decisions about disease ... ...
Breaking Biology Technology: